John Mee

Guy's and St Thomas' NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

18h-index1.2kcitations57works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune Bullous Skin Diseases(23), Urticaria and Related Conditions(14), Coagulation, Bradykinin, Polyphosphates, and Angioedema(11), Psoriasis: Treatment and Pathogenesis(10), Skin and Cellular Biology Research(10)

Publications57 total

P040 Clinical features, treatment and treatment response of 24 patients with epidermolysis bullosa acquisita
British Journal of Dermatology·2025Open Access
BG13 Pemphigoid vegetans of the buttocks
British Journal of Dermatology·2025Open Access
Recurrent balanoposthitis and oral blistering in a young man
Clinical and Experimental Dermatology·2024
Treatment with shRNA to knockdown the 5-HT2A receptor improves memory in vivo and decreases excitability in primary cortical neurons
Genomic psychiatry :·2024· 1 citedOpen Access
Efficacy of rituximab in the treatment of epidermolysis bullosa acquisita
Clinical and Experimental Dermatology·2024· 1 cited
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus
British Journal of Dermatology·2024
Histopathology of the Skin: General Principles
2024
Diagnostic Techniques in Autoimmune Blistering Diseases
British Journal of Biomedical Science·2023· 10 citedOpen Access
P18 Epidermolysis bullosa acquisita in children: report of three cases
British Journal of Dermatology·2023
P19 Pemphigus foliaceus in a 13-year-old child
British Journal of Dermatology·2023
P19 Diagnostic conundrums in paraneoplastic pemphigus
British Journal of Dermatology·2023Open Access
Immunobullous Transformation of Protracted Psoriasis: A Diagnostic Dilemma
Cureus·2023· 1 citedOpen Access
Atezolizumab-induced linear IgA bullous dermatosis
British Journal of Dermatology·2022· 5 cited
Epidermolysis bullosa aquisita following immune-checkpoint inhibitor treatment for metastatic melanoma
Clinical and Experimental Dermatology·2022· 3 cited
Epidermolysis bullosa acquisita: a case series of three paediatric patients
Clinical and Experimental Dermatology·2022· 2 cited
Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid
Ophthalmology·2020· 25 citedOpen Access
A study into the best sites to biopsy for a diagnosis of pemphigus vulgaris or mucous membrane pemphigoid
British Journal of Dermatology·2020· 1 citedOpen Access
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa
Journal of the American Academy of Dermatology·2019· 109 citedOpen Access
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa
JCI Insight·2019· 88 citedOpen Access
Lichen Planus Pemphigoides Mimicking Toxic Epidermal Necrolysis
American Journal of Dermatopathology·2019· 9 cited
page 1 of 3Next →

Frequent Co-authors

Richard Groves(22), Jemima E. Mellerio(6), Michael J. Cork(6), John A. McGrath(5), Francesco S. di Giovine(4), Jane Setterfield(4), Lu Liu(3), Linda Ozoemena(3), Gabriela Petrof(3), Christos Antonopoulos(3), G.W. Duff(3), Barbara Carey(3), Gordon W. Duff(3), Jean-Baptiste Barbaroux(3), S.S. Bleehen(3), Thomas J Tull(3), Eduardo Calonje(3), Patricia A. Lovell(2), Joey E. Lai‐Cheong(2), Ellie Rashidghamat(2)